Recent News

• 10.20.2025 - ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
• 10.20.2025 - ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
• 10.13.2025 - ProQR to Participate in Upcoming Investor Conferences in October 2025
• 10.13.2025 - ProQR to Participate in Upcoming Investor Conferences in October 2025
• 08.07.2025 - ProQR Announces Second Quarter 2025 Operating and Financial Results
• 07.28.2025 - ProQR Announces Upcoming Presentation at RNA Editing Summit
• 07.28.2025 - ProQR Announces Upcoming Presentation at RNA Editing Summit
• 07.28.2025 - ProQR Announces Upcoming Presentation at RNA Editing Summit
• 06.26.2025 - ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
• 06.26.2025 - ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP

Recent Filings

• 10.20.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.20.2025 - EX-99.1 EX-99.1
• 09.30.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 09.04.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.20.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.07.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.07.2025 - EX-99.1 EX-99.1
• 06.26.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]